-
1
-
2by Max Robinson, Jacqueline James, Gareth Thomas, Nicholas West, Louise Jones, Jessica Lee, Karin Oien, Alex Freeman, Clare Craig, Philip Sloan, Philip Elliot, Maggie Cheang, Manuel Rodriguez‐Justo, Clare Verrill, on behalf of the UK National Cancer Research Institute (NCRI) Cellular‐Molecular Pathology (CM‐Path) clinical trials working groupGet full text
Published 2019-04-01
Article